Investor Relations Information for shareholders and investors of Sumitomo Pharma, including management policies, IR materials, and stock and shareholder-related information. Pick Up Integrated Report 2023 Sumitomo Pharma's DX Frontier Business Website ...
Shingo Ueno, Executive Vice President, Head of Energy Innovation Initiative Presentation Material (PDF/2130KB) Presentation with Script (PDF/1690KB) Questions and Answers (PDF/128KB) Investor Relations Contact Form Order Report Social Media Official Account LinkedIn Share...
Presentation for the Conference on the Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture Dec. 17, 2024 Presentation Material (Sumitomo Chemical Co., Ltd. )(PDF/671KB) Dec. 17, 2024 Presentation Material (Sumitomo Pharma Co., Ltd. )(PDF/552KB) ...
A Turnkey Solution The scope included chemical and radiological remediation, planning, construction, excavation, waste transportation and disposal, final status survey (FSS), restoration, and regulatory closeout of the site. Technical Competence
Investor RelationsRB Milestone Group, LLC (RBMG) at minehub@rbmilestone.com Cautionary Note Regarding Forward-Looking StatementsNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange)...